Opioids - As enacted, adds Alvogen, Inc., Apotex Corp., and Zydus Pharmaceuticals (USA) Inc. to the list of companies that may be released by the attorney general for pending or future claims regarding opioids. - Amends TCA Title 20 and Title 33.
Pub. Ch. 888
Summary
The bill amends state law to include three additional drug manufacturers—Alvogen, Inc., Apotex Corp., and Zydus Pharmaceuticals (USA) Inc.—alongside Purdue Pharma in the list of firms the attorney general may pursue for opioid-related claims. It updates two code sections and takes effect immediately, expanding the pool of companies that could be held liable for opioid harms.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get an email when SB 1495 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track SB 1495 freeOr ask your AI assistant about SB 1495 directly:
Add to Claude, ChatGPT or Cursor